Common medication for lung cancer symptoms found to limit effectiveness of cancer treatment
LOS ANGELES — Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer patients treated with immunotherapy, are the main reason certain…
Read the full articleYou might also wanna read
Nature Medicine retracts study claiming morning immunotherapy improves lung cancer outcomes
Investigation finds problems in a key clinical trial that critics said was too good to be true
science.org·14d ago
New drug for cancer patients with ‘limited’ treatment options enters clinical trial
Scientists have expressed ‘excitement’ over the potential new treatment for advanced adrenocortical carcinoma (ACC)
The immunology of human breast cancer
Immunotherapy with ICIs transforms melanoma & lung cancer care, but most breast cancers, except triple-negative ones, resist. PMID:42151556,
Anti-inflammatory drugs show promise for lung cancer prevention, new research finds
A molecular signature can identify those most at risk
economist.com·21d ago
Blood-brain barrier-like vascular gate identified as key driver of immunotherapy resistance in small cell lung cancer
A blood-brain barrier-like vascular gate in small cell lung cancer and other neuroendocrine cancers blocks immune cells and drives resistanc
Lipid nanoparticle platform delivers chemo drug and RNA to boost immune response against lung cancer
Researchers at the University of Arizona R. Ken Coit College of Pharmacy have developed a new strategy that helps the immune system recogniz
news-medical.net·14d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.